Arrowhead Pharmaceuticals Inc. buy Royal Bank of Canada
Start price
30.11.23
/
50%
€22.00
Target price
30.11.24
€45.85
Performance (%)
-22.41%
Price
03.10.24
€17.07
Summary
This prediction is currently active. The price of Arrowhead Pharmaceuticals Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -22.41%. This prediction currently runs until 30.11.24. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Arrowhead Pharmaceuticals Inc. | -3.149% | -3.149% |
iShares Core DAX® | -1.114% | 3.430% |
iShares Nasdaq 100 | 1.816% | 6.911% |
iShares Nikkei 225® | 2.113% | 5.501% |
iShares S&P 500 | 2.038% | 5.327% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $50.00 price target on the stock.
Ratings data for ARWR provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€17.62
26.09.24
26.09.24
€37.69
26.09.25
26.09.25
-3.09%
03.10.24
03.10.24
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€29.40
07.02.24
07.02.24
€46.44
07.02.25
07.02.25
-41.94%
03.10.24
03.10.24
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€31.94
16.01.24
16.01.24
€45.92
16.01.25
16.01.25
-46.56%
03.10.24
03.10.24
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€25.07
08.08.23
08.08.23
€54.74
08.08.24
08.08.24
-10.25%
09.08.24
09.08.24